Advertisement Valeant Pharmaceuticals divests Argentina operations - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Valeant Pharmaceuticals divests Argentina operations

Valeant Pharmaceuticals International has divested its Argentina commercial operations to one of the pharmaceutical companies in Argentina.

Michael Pearson, chairman and CEO of Valeant, said: “One of our strategic initiatives for 2008 is to divest certain regions and simplify our operations. The sale of our business in Argentina is another important step forward in executing on our strategy.”